Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Pastimes : Clown-Free Zone... sorry, no clowns allowed -- Ignore unavailable to you. Want to Upgrade?

To: LLCF who wrote (150588)	2/11/2002 10:37:51 AM
From: Cactus Jack	Read Replies (2) \| Respond to of 436258

Here's a good one. PRU downgrades NEM to a Sell rating, cuts price target to $10: finance.yahoo.com jpgill

To: LLCF who wrote (150588)	2/11/2002 12:08:59 PM
From: reaper	Read Replies (1) \| Respond to of 436258

To DAK & others re:<<I'm clown long CBST, CRXA, SEPR>> There may be a good event opportunity coming up in Sepracor. SEPR has a drug, Soltara, that is in FDA review process right now. This is a make or break event for SEPR; if they get turned down they are hosed, as they are building up a VERY large expense infrastructure to sell this drug. Anyway, the Prescription Drug User Fee Act (PDUFA -- oops, there I go again worrying about the minutiae of gov't regulation; sorry) date for Soltara is 9 March. If they get an approvable letter around that date, on would think that the stock would soar, and if they get turned down one would think the stock tanks. This date is pretty well known, I think, so if it were to pass with no action I imagine people would get worried. Anyway, that's near-term (only about 4 weeks from today) so I would imagine you options mavens could work out a strategy to take advantage of this likely upcoming event risk and volatility. Sorry for that interuption; I will now just go back to my bear practice of "hoping for P/Es to decline". Cheers